523 related articles for article (PubMed ID: 33868295)
1. EZH2 Inhibition Interferes With the Activation of Type I Interferon Signaling Pathway and Ameliorates Lupus Nephritis in NZB/NZW F1 Mice.
Wu L; Jiang X; Qi C; Zhang C; Qu B; Shen N
Front Immunol; 2021; 12():653989. PubMed ID: 33868295
[TBL] [Abstract][Full Text] [Related]
2. Identification of Cyclin-Dependent Kinase 1 as a Novel Regulator of Type I Interferon Signaling in Systemic Lupus Erythematosus.
Wu L; Qin Y; Xia S; Dai M; Han X; Wu Y; Zhang X; Ma J; Wang Y; Tang Y; Liu Z; Zhu W; Jallal B; Yao Y; Qu B; Shen N
Arthritis Rheumatol; 2016 May; 68(5):1222-32. PubMed ID: 26663909
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of Renal Hsa-miR-127-3p Contributes to the Overactivation of Type I Interferon Signaling Pathway in the Kidney of Lupus Nephritis.
Wu L; Han X; Jiang X; Ding H; Qi C; Yin Z; Xiao J; Xiong L; Guo Q; Ye Z; Qu B; Shen N
Front Immunol; 2021; 12():747616. PubMed ID: 34745118
[TBL] [Abstract][Full Text] [Related]
4. Pim-1 as a Therapeutic Target in Lupus Nephritis.
Fu R; Xia Y; Li M; Mao R; Guo C; Zhou M; Tan H; Liu M; Wang S; Yang N; Zhao J
Arthritis Rheumatol; 2019 Aug; 71(8):1308-1318. PubMed ID: 30791224
[TBL] [Abstract][Full Text] [Related]
5. CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice.
Moser K; Kalies K; Szyska M; Humrich JY; Amann K; Manz RA
Arthritis Rheum; 2012 Apr; 64(4):1237-46. PubMed ID: 22006377
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of EZH2 Ameliorates Lupus-Like Disease in MRL/lpr Mice.
Rohraff DM; He Y; Farkash EA; Schonfeld M; Tsou PS; Sawalha AH
Arthritis Rheumatol; 2019 Oct; 71(10):1681-1690. PubMed ID: 31106974
[TBL] [Abstract][Full Text] [Related]
7. Enhancer of zeste homolog 2-catalysed H3K27 trimethylation plays a key role in acute-on-chronic liver failure via TNF-mediated pathway.
Zhou T; Sun Y; Li M; Ding Y; Yin R; Li Z; Xie Q; Bao S; Cai W
Cell Death Dis; 2018 May; 9(6):590. PubMed ID: 29789597
[TBL] [Abstract][Full Text] [Related]
8. Punicalagin Ameliorates Lupus Nephritis via Inhibition of PAR2.
Seo Y; Mun CH; Park SH; Jeon D; Kim SJ; Yoon T; Ko E; Jo S; Park YB; Namkung W; Lee SW
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32674502
[TBL] [Abstract][Full Text] [Related]
9. EZH2 inhibition dampens autoantibody production in lupus by restoring B cell immune tolerance.
Yang Y; Li M; Zhu Y; Liu K; Liu M; Liu Y; Zhu G; Luo H; Zuo X; Zhang H; Guo M
Int Immunopharmacol; 2023 Jun; 119():110155. PubMed ID: 37044035
[TBL] [Abstract][Full Text] [Related]
10. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
Enghard P; Langnickel D; Riemekasten G
Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
[TBL] [Abstract][Full Text] [Related]
11. TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.
Bodewes ILA; Huijser E; van Helden-Meeuwsen CG; Tas L; Huizinga R; Dalm VASH; van Hagen PM; Groot N; Kamphuis S; van Daele PLA; Versnel MA
J Autoimmun; 2018 Jul; 91():97-102. PubMed ID: 29673738
[TBL] [Abstract][Full Text] [Related]
12. Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis.
Jiang Y; Xiang C; Zhong F; Zhang Y; Wang L; Zhao Y; Wang J; Ding C; Jin L; He F; Wang H
Theranostics; 2021; 11(1):361-378. PubMed ID: 33391480
[No Abstract] [Full Text] [Related]
13. The Ox40/Ox40 Ligand Pathway Promotes Pathogenic Th Cell Responses, Plasmablast Accumulation, and Lupus Nephritis in NZB/W F1 Mice.
Sitrin J; Suto E; Wuster A; Eastham-Anderson J; Kim JM; Austin CD; Lee WP; Behrens TW
J Immunol; 2017 Aug; 199(4):1238-1249. PubMed ID: 28696253
[TBL] [Abstract][Full Text] [Related]
14. JAK inhibitor has the amelioration effect in lupus-prone mice: the involvement of IFN signature gene downregulation.
Ikeda K; Hayakawa K; Fujishiro M; Kawasaki M; Hirai T; Tsushima H; Miyashita T; Suzuki S; Morimoto S; Tamura N; Takamori K; Ogawa H; Sekigawa I
BMC Immunol; 2017 Aug; 18(1):41. PubMed ID: 28830352
[TBL] [Abstract][Full Text] [Related]
15. IFN-α confers resistance of systemic lupus erythematosus nephritis to therapy in NZB/W F1 mice.
Liu Z; Bethunaickan R; Huang W; Ramanujam M; Madaio MP; Davidson A
J Immunol; 2011 Aug; 187(3):1506-13. PubMed ID: 21705616
[TBL] [Abstract][Full Text] [Related]
16. DNA-dependent activator of interferon-regulatory factors (DAI) promotes lupus nephritis by activating the calcium pathway.
Zhang W; Zhou Q; Xu W; Cai Y; Yin Z; Gao X; Xiong S
J Biol Chem; 2013 May; 288(19):13534-50. PubMed ID: 23553627
[TBL] [Abstract][Full Text] [Related]
17. Abnormalities of the type I interferon signaling pathway in lupus autoimmunity.
Gallucci S; Meka S; Gamero AM
Cytokine; 2021 Oct; 146():155633. PubMed ID: 34340046
[TBL] [Abstract][Full Text] [Related]
18. Interferon (IFN)-inducible Absent in Melanoma 2 proteins in the negative regulation of the type I IFN response: Implications for lupus nephritis.
Choubey D; Panchanathan R
Cytokine; 2020 Aug; 132():154682. PubMed ID: 30904426
[TBL] [Abstract][Full Text] [Related]
19. Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease.
Mavragani CP; Sagalovskiy I; Guo Q; Nezos A; Kapsogeorgou EK; Lu P; Liang Zhou J; Kirou KA; Seshan SV; Moutsopoulos HM; Crow MK
Arthritis Rheumatol; 2016 Nov; 68(11):2686-2696. PubMed ID: 27338297
[TBL] [Abstract][Full Text] [Related]
20. In lupus nephritis, how do extracellular DNAs trigger type I interferon secretion: Under the assistance of HMGB1-cGAS?
Zheng L; Zhang H; Tang Y
Med Hypotheses; 2018 Dec; 121():51-53. PubMed ID: 30396490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
